NO‐Enhanced Sonodynamic Nanovesicles with Co‐Stimulatory Molecule Self‐Presentation for Multidimensional Tumor Immunotherapy
Authors:
- 12 May 2025
- journal article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 64 (26) , e202504684
Abstract
Synergistically improving T cell responsiveness represents a promising therapeutic strategy for tumors; however, current treatments struggle to fully activate cancer‐immunity cascade. We propose a novel gas‐assisted sonosensitizer‐loaded biomimetic nanoplatform, triggering ultrasonic‐sensitive tumor immunogenic cell death (ICD) and cascading immune activation. Upon ultrasound stimulation, the nanocore liberates reactive oxygen species and nitric oxide, generating highly toxic peroxynitrite (ONOO − ) in situ. The ONOO − then orchestrated several intracellular events, including protein S ‐nitrosylation, endoplasmic reticulum stress, Ca 2+ dyshomeostasis‐mediated mitochondrial dysfunction, and ICD‐enhanced immune cell recruitment. Furthermore, the biomimetic artificial dendritic cell (DC) membranes, from genetically engineered tumor cells, simultaneously present peptide‐major histocompatibility complex class I (pMHC‐I) and CD86, enabling homologous tumor targeting but also mimicking the antigen presentation and costimulatory signaling of DCs to directly activate infiltrating T lymphocytes. In multiple murine models, this nanovaccine demonstrated remarkable therapeutic efficacy, including tumor suppression, long‐lasting antitumor immunity, and tumor metastasis inhibition. The ultrasound‐responsive nanoDCs offer a promising paradigm for multifaceted immune boosters to address the challenges of immune tolerance and suboptimal patient response.Keywords
Funding Information
- National Natural Science Foundation of China (T2422030)
- National Natural Science Foundation of China (32471462)
- National Natural Science Foundation of China (82172081)
- Fundamental Research Funds for the Central Universities (2021‐RC350‐006)
This publication has 53 references indexed in Scilit:
- An Acceptor–Donor–Acceptor Structured Nano‐Aggregate for NIR‐Triggered Interventional Photoimmunotherapy of Cervical CancerAdvanced Materials, 2024
- Photo‐Triggered Cascade Therapy: A NIR‐II AIE Luminogen Collaborating with Nitric Oxide Facilitates Efficient Collagen Depletion for Boosting Pancreatic Cancer PhototheranosticsAdvanced Materials, 2024
- Strategies to Reverse Hypoxic Tumor Microenvironment for Enhanced Sonodynamic TherapyAdvanced Healthcare Materials, 2023
- Harnessing Nanomaterials for Cancer Sonodynamic ImmunotherapyAdvanced Materials, 2023
- Tumor‐Specific Peroxynitrite Overproduction Disrupts Metabolic Homeostasis for Sensitizing Melanoma ImmunotherapyAdvanced Materials, 2023
- Supramolecular Nitric Oxide Depot for Hypoxic Tumor Vessel Normalization and RadiosensitizationAdvanced Materials, 2022
- A Self‐Reporting Fluorescent Salicylaldehyde–Chlorambucil Conjugate as a Type‐II ICD Inducer for Cancer VaccinesAdvanced Materials, 2022
- Targeting immunogenic cell death in cancerMolecular Oncology, 2020
- Recent Advances in Nanomaterial‐Assisted Combinational Sonodynamic Cancer TherapyAdvanced Materials, 2020
- Homotypic Targeting Delivery of siRNA with Artificial Cancer CellsAdvanced Healthcare Materials, 2020